Sanofi, a French pharmaceutical company intend to introduce more innovative treatments into the local market as a result of recent government incentives and encouraging steps to accelerate the introduction of breakthrough medications. Last year, Sanofi had achieved to launch 25 innovative products in China, which was two years ahead of the schedule. The aim here is to potentially speed up the release of China’s most innovative medicines as soon as possible, and the Collaboration between China-France will help anchor the local healthcare ecosystem.
